Suppression of graft-versus-host disease and retention of graft-versus-tumour reaction by murine genetically engineered dendritic cells following bone marrow transplantation.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Molecular Medicine Reports

• Publication date

  2015-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/mmr.2014.3123PMID 25529231
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparable long-term outcome of unrelated cord blood transplantation with related bone marrow or peripheral blood stem cell transplantation in patients aged 45 years or older with hematologic malignancies after myeloablative conditioning.

  2014cited by this paper
• The Role of Dendritic Cells in Graft-Versus-Tumor Effect

  2014cited by this paper
• Dendritic Cells Are the Major Antigen Presenting Cells in Inflammatory Lesions of Murine Mycoplasma Respiratory Disease

  2013cited by this paper
• Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence.

  2013cited by this paper
• Immune tolerance induced by intravenous transfer of immature dendritic cells via up-regulating numbers of suppressive IL-10+ IFN-γ+-producing CD4+ T cells

  2013cited by this paper
• Adherent and non-adherent dendritic cells are equivalently qualified in GM-CSF, IL-4 and TNF-α culture system.

  2012cited by this paper
• Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity.

  2012cited by this paper
• Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow.

  2012cited by this paper
• Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice.

  2011cited by this paper
• Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new.

  2011cited by this paper
• Therapeutic plasticity of stem cells and allograft tolerance.

  2011cited by this paper
• Dual role of anti-TNF therapy: enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues.

  2011cited by this paper
• Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice

  2011cited by this paper
• DCs in immune tolerance in steady-state conditions.

  2011cited by this paper
• [Establishment and identification of mouse lymphoma cell line EL4 expressing red fluorescent protein].

  2010cited by this paper
• Critical Role for TNF in the Induction of Human Antigen-Specific Regulatory T Cells by Tolerogenic Dendritic Cells

  2010cited by this paper
• How tolerogenic dendritic cells induce regulatory T cells.

  2010cited by this paper
• Antileukemia and antitumor effects of the graft-versus-host disease: a new immunovirological approach.

  2010cited by this paper
• Efficacy of pretreatment of allografts with methoxypolyethylene glycol-succinimidyl-propionic acid ester in combination with an anti-OX40L monoclonal antibody in relieving graft-versus-host disease in mice

  2010cited by this paper
• Induction of type 2 T helper cell allergen tolerance by IL-10-differentiated regulatory dendritic cells.

  2010cited by this paper
• Engineered regulatory T cells prevent graft-versus-host disease while sparing the graft-versus-leukemia effect after bone marrow transplantation.

  2010cited by this paper
• Induction of graft-versus-leukemia (GVL) effect without graft-versus-host disease (GVHD) by pretransplant donor treatment with immunomodulators.

  2009cited by this paper
• Bone marrow deficient in IFN-{gamma} signaling selectively reverses GVHD-associated immunosuppression and enhances a tumor-specific GVT effect.

  2009cited by this paper
• Ligand of scavenger receptor class A indirectly induces maturation of human blood dendritic cells via production of tumor necrosis factor-alpha.

  2009cited by this paper
• Tumour necrosis factor alpha blockade impairs dendritic cell survival and function in rheumatoid arthritis

  2009cited by this paper
• Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.

  2009cited by this paper
• Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

  2009cited by this paper
• Regulatory mechanisms in graft-versus-host responses.

  2009cited by this paper
• Distinct Effect of CD40 and TNF-Signaling on the Chemokine/Chemokine Receptor Expression and Function of the Human Monocyte-Derived Dendritic Cells

  2008cited by this paper
• Acute GvHD: pathogenesis and classification

  2008cited by this paper
• Pathophysiology of acute graft-versus-host disease: recent advances.

  2007cited by this paper
• Immunosuppression induced by immature dendritic cells is mediated by TGF-β/IL-10 double-positive CD4+ regulatory T cells

  2007cited by this paper
• Interaction between Transmembrane TNF and TNFR1/2 Mediates the Activation of Monocytes by Contact with T Cells1

  2007cited by this paper
• Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response.

  2006cited by this paper
• Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity.

  2005cited by this paper
• Induction of mixed vs full chimerism to potentiate GVL effects after bone-marrow transplantation.

  2005cited by this paper
• TGF-β1 gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo

  2002cited by this paper
• TGF-beta(1) gene modified immature dendritic cells exhibit enhanced tolerogenicity but induce allograft fibrosis in vivo.

  2002cited by this paper
• Haematopoietic cell transplantation as immunotherapy

  2001cited by this paper
• TNF-α-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection

  2001cited by this paper
• Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.

  1998cited by this paper
• Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.

  1997cited by this paper
• An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.

  1996cited by this paper

• Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models

  2023cites this paper
• [Study on the immune functions of dendritic cells regulated by histone deacetylase inhibitor Belinostat].

  2018cites this paper
• IL-10 gene-modified dendritic cells-induced type 1 T regulatory cells inhibit graft-versus-host disease while preserving graft-versus-leukemia effect.

  2018cites this paper
• Effects of regulatory dendritic cells on graft-versus-host disease and graft-versus-leukemia in mice after allogeneic bone marrow transplantation

  2018cites this paper
• 组蛋白去乙酰化酶抑制剂Belinostat对髓源性树突状细胞免疫功能的作用研究

  2018cites this paper